Kyle Fraher

Kyle Fraher has a strong background in program and project management within the pharmaceutical industry. Kyle is currently serving as the Vice President of Program Management at XinThera Inc. since March 2022. Prior to this, they held the role of Vice President of Project Management at Lengo Therapeutics from September 2021 to March 2022.

In 2021, Kyle worked as the Executive Director at Ionis Pharmaceuticals, Inc. from February to September. Before that, they held the position of Executive Director of Program Management at Intercept Pharmaceuticals from August 2016 to February 2021. Kyle also served as the Senior Director of Program Management at Intercept Pharmaceuticals from May 2014 to July 2016, where they managed a team of professionals and led program management efforts for various projects.

Kyle's earlier experience includes the role of Director of Project Management at Arena Pharmaceuticals from May 2011 to April 2014. At Biogen Idec, they worked as the Director of Program and Alliance Management from April 2005 to January 2011, leading cross-functional program strategy and development teams. Prior to that, they served as the Senior Manager of Clinical Affairs at Genentech from November 1999 to March 2005.

Kyle's career began as a Research Manager at the Technology Assessment Group (TAG) from August 1996 to November 1999, where they specialized in health economic studies and disease registries.

Overall, Kyle Fraher has extensive experience in program and project management, with a focus on the pharmaceutical industry. Their roles have involved leading teams, managing projects, and providing strategic guidance for successful program implementation.

Kyle Fraher has a Bachelor of Science degree in Anthropology and Human Biology from Emory University. Kyle also completed a Master's degree program in Biostatistics and Epidemiology at Georgetown University. In addition, Kyle participated in a Graduate Summer Program in Epidemiology at The Johns Hopkins University. No specific start or end dates were provided for any of their education experiences.